Loading…
Lobbying Spend
—
Filings
9
Firms Hired
1
Active Period
2024–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
2026 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.9260/S.____, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2027, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
Client expense: — · Firm income: $30,000
Matched citations: H.R.9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
2026 · second_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.9260/S.____, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2027, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
Client expense: — · Firm income: $30,000
Matched citations: H.R.9260
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
2025 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.3838/S.2296, National Defense Authorization Act, 2026, Title II, all provisions related to biodefense preparedness.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3838
POST Act of 2025
2025 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.4026/S.2572, Department of Defense Appropriations Bill, 2026, Title IV, all provisions related to biodefense preparedness. H.R.5304/S.2587, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
Client expense: — · Firm income: $30,000
Matched citations: H.R.4026
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.4026/S.2572, Department of Defense Appropriations Bill, 2026, Title IV, all provisions related to biodefense preparedness. H.R.5304/S.2587, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5304
National Defense Authorization Act for Fiscal Year 2026
2025 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.3838/S.2296, National Defense Authorization Act, 2026, Title II, all provisions related to biodefense preparedness.
Client expense: — · Firm income: $30,000
Matched citations: S.2296
Department of Defense Appropriations Act, 2026
2025 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.4026/S.2572, Department of Defense Appropriations Bill, 2026, Title IV, all provisions related to biodefense preparedness. H.R.5304/S.2587, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
Client expense: — · Firm income: $30,000
Matched citations: S.2572
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.4026/S.2572, Department of Defense Appropriations Bill, 2026, Title IV, all provisions related to biodefense preparedness. H.R.5304/S.2587, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
Client expense: — · Firm income: $30,000
Matched citations: S.2587
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
2025 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.3838/S.2296, National Defense Authorization Act, 2026, Title II, all provisions related to biodefense preparedness.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3838
POST Act of 2025
2025 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.4026/S.2572, Department of Defense Appropriations Bill, 2026, Title IV, all provisions related to biodefense preparedness. H.R.5304/S.2587, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
Client expense: — · Firm income: $30,000
Matched citations: H.R.4026
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.4026/S.2572, Department of Defense Appropriations Bill, 2026, Title IV, all provisions related to biodefense preparedness. H.R.5304/S.2587, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5304
National Defense Authorization Act for Fiscal Year 2026
2025 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.3838/S.2296, National Defense Authorization Act, 2026, Title II, all provisions related to biodefense preparedness.
Client expense: — · Firm income: $30,000
Matched citations: S.2296
Department of Defense Appropriations Act, 2026
2025 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.4026/S.2572, Department of Defense Appropriations Bill, 2026, Title IV, all provisions related to biodefense preparedness. H.R.5304/S.2587, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
Client expense: — · Firm income: $30,000
Matched citations: S.2572
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.4026/S.2572, Department of Defense Appropriations Bill, 2026, Title IV, all provisions related to biodefense preparedness. H.R.5304/S.2587, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
Client expense: — · Firm income: $30,000
Matched citations: S.2587
POST Act of 2025
2025 · second_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.4026/S.____, Department of Defense Appropriations Bill, 2026, Title IV, all provisions related to biodefense preparedness. H.R.____/S.____, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
Client expense: — · Firm income: $30,000
Matched citations: H.R.4026
National Defense Authorization Act for Fiscal Year 2026
2025 · second_quarter · Firm: INNOVATIVE FEDERAL STRATEGIES, LLC
H.R.____/S.2296, National Defense Authorization Act, 2026, Title II, all provisions related to biodefense preparedness.
Client expense: — · Firm income: $30,000
Matched citations: S.2296
Source: Senate LDA